Adult Opioid Use Michigan: What the Latest Research Data Reveals About Declining Overdose Rates
Adult opioid use data for Michigan reveals an encouraging change: overdose deaths have declined for three years in a row, with a projected 34% reduction between 2023 and 2024. This represents around 1,000 fewer deaths and positions Michigan among the top five states for greatest reduction in overdose fatalities. The challenge remains substantial though. Michigan reported 2,422 opioid overdose deaths in 2022, and opioids still account for nearly 3 in 4 of the state’s overdose deaths. To understand opioid use in Michigan, we must dissect current statistics, historical trends and the factors driving these improvements. This resource explores what recent research reveals about declining rates and the role of Michigan opioid laws. It also examines the ongoing challenges that adult populations face across the state.
Current State of Adult Opioid Use in Michigan
2024 Overdose Statistics and Death Rates
Provisional data from the Michigan Department of Health and Human Services shows the state recorded 2,826 overdose deaths in 2023, down from 2,998 in 2022. This 5.7% decrease marks a most important move in adult opioid use in Michigan. The overall overdose death rate has dropped from its peak of 31.1 deaths per 100,000 residents in 2021 to 28.2 in 2023.
Michigan recorded 1,505 overdose deaths between January and September 2024, compared to 2,931 deaths for the whole year of 2023. Dr. Natasha Bagdasarian, Michigan’s chief medical executive, confirmed the state now ranks among the top five states for greatest reduction in overdose deaths.
The Michigan Opioids Task Force distributed more than 1.3 million naloxone kits through settlement funding. Nearly 34,000 of those kits were used to reverse overdoses. State officials note that nonfatal overdoses remain high despite these improvements.
Racial disparities persist within the data. The 2023 provisional figures show that Black residents are 2.8 times and American Indian/Alaska Native residents are 2.2 times more likely to die of an overdose than white residents.
Economic Effect on Michigan Communities
Opioid addiction cost Michigan nearly $40 billion in 2024. Research from Avalere Health found this figure has more than $10 billion in lost wages and $7 billion from local and federal governments. Companies paid nearly $20 billion for insurance and lost productivity.
Each case of opioid use disorder in Michigan carries an annual cost of $742,799. The economic burden extends beyond direct healthcare expenses. Michigan residents lost the equivalent of $123 billion through reduced quality of life and earlier deaths.
Michigan is slated to receive more than $1.8 billion from national opioid settlements by 2040. Half goes to the Michigan Opioid Healing and Recovery Fund, while the remaining half distributes to county, city and township governments.
Comparison to National Trends
Michigan’s decline from 2021 to 2023 is almost five times greater than the national decline seen in that same timeframe. The state projected it would receive more than $1 billion from opioid settlement payments over the next 20 years.
Over 75% of the nearly 107,000 drug overdose deaths in the United States in 2021 involved opioids. Michigan’s performance positions it ahead of most states in addressing opioid use in michigan through coordinated prevention and treatment efforts.
Historical Trends in Michigan Opioid Deaths (2000-2024)
Peak Years and the COVID-19 Effect
Adult opioid use Michigan mortality patterns went through dramatic changes between 2000 and 2024. The state recorded 183 opioid overdose deaths in 2000. Two rapid increase periods emerged: death rates surged by 23.3% annually from 2000 to 2006 and remained relatively stable until 2012. A second wave accelerated between 2012 and 2017, with rates climbing 23.1% each year.
The crisis peaked in 2017 with 2,053 total opioid deaths. Deaths remained high through 2018 (2,036) before dipping to 1,768 in 2019. Then COVID-19 arrived. The age-adjusted opioid overdose death rate jumped 25% from 2019 to 2020, rising from 18.1 per 100,000 to 22.6. Live tracking showed deaths climbing from 30-40 per week in early 2020 to over 40 weekly by mid-March and peaking in early June. The pandemic’s effect pushed deaths to 2,176 in 2020 and 2,421 in 2021.
Three-Year Decline Pattern Since 2022
Michigan opioid deaths decreased steadily since their 2021 peak of 2,539. The state recorded 2,422 deaths in 2022 and 2,287 in 2023. Provisional 2024 data shows 1,342 deaths through the reporting period, representing the third consecutive year of decline. Males consistently factored in approximately 70% of deaths throughout this period, with 1,713 male deaths versus 709 female deaths in 2022.
Types of Opioids Involved in Overdose Deaths
The composition of opioid use in michigan went through dramatic changes over two decades. Prescription opioid deaths peaked at 697 in 2016 before declining to 282 by 2024. Heroin-involved deaths rose from 89 in 2000 to 786 in 2017, then dropped sharply to just 69 in 2024. Prescription and heroin deaths declined, but synthetic opioids other than methadone surged from 17 deaths in 2000 to 2,287 in 2021. Synthetic opioid death rates exceeded all other opioid types by 2016. Fentanyl dominated 70% of rural Michigan overdose deaths by 2020.
Factors Behind Declining Overdose Rates
Opioid Settlement Funds and Resource Allocation
Several interventions account for declining adult opioid use Michigan rates. The Michigan Department of Health and Human Services invested $10 million from opioid settlement funds in harm reduction programs during FY2024. The state expects to receive more than $800 million over 18 years as part of the nationwide settlement with pharmaceutical distributors and Johnson & Johnson.
Settlement allocations target vulnerable populations experiencing the highest disparities. Nearly $1.8 billion in total settlement funds will flow to Michigan governments by 2040. Half goes to the Michigan Opioid Healing and Recovery Fund, and half goes to county, city, and township governments. FY2025 prevention efforts received $8 million and supported Quick Response Teams ($1.7 million), Naloxone Direct ($2.4 million), and Syringe Service Programs ($6.4 million).
Naloxone Distribution and Reported Reversals
Michigan distributed more than 1 million naloxone kits through its Naloxone Direct Portal. This led to at least 21,642 overdose reversals since the 2020 launch. Opioid settlement dollars funded nearly 150,000 kit distributions in FY23 alone and reversed nearly 2,600 overdoses. Nearly 25,000 kits reached both Detroit and Flint. Harm reduction modeling shows more than 1,650 deaths prevented between 2017 and 2024 due to increased naloxone access.
Evidence-Based Treatment Programs
Michigan expanded Medicaid substance use disorder providers by removing barriers and offering loan repayment incentives. The state removed prior authorization requirements for medications that treat opioid use disorder. This allowed a 20% increase over four years in MOUD prescriptions by primary care physicians. Officials expanded opioid treatment capacity at 10 Michigan Department of Corrections prisons and provided MOUD to 884 incarcerated individuals.
Data Systems and Early Detection Tools
The System for Opioid Overdose Surveillance (SOS) maps non-fatal and fatal overdose incidents immediately for authorized public health and public safety users. The Michigan Opioid Overdose Data to Action (MODA) Dashboard provides county and zip code level data on current trends, disparities, and treatment access. These surveillance tools guide resource allocation for rapid response and prevention efforts statewide.
Adult Population Patterns and Ongoing Challenges
Older Adults (55+) and Chronic Pain Management
79,893 Americans age 55 and older died from opioid overdoses between 1999 and 2019. Opioid use disorder in adults 65 and older more than tripled between 2013 and 2018. 12.8 percent of adults aged 65 and older filled at least one outpatient opioid prescription in 2020-2021, and 4.4 percent had four or more prescription fills during the year.
Chronic pain drives prescription patterns in this demographic. About 40 percent of older adults report pain, compared to 30 percent of the general population. Older women were more likely to fill at least one opioid prescription (14.0 percent) and to have four or more fills (5.3 percent) than older men (11.3 percent and 3.4 percent). Opioids affect older adults more strongly because bodily processes slow as people age.
Rural vs Urban Opioid Use Differences
Michigan’s urban counties had higher opioid overdose death rates than rural counties, whereas rural counties had higher opioid prescribing rates. The rate of drug overdose deaths was higher in urban counties (28.6 per 100,000) than in rural counties (26.2).
Access to treatment reveals stark disparities. Seventy-four percent of rural counties and 48 percent of urban counties have low-to-no capacity for buprenorphine. Among rural counties with high need, 65 percent have low-to-no capacity for buprenorphine prescribing, compared with 41 percent of urban counties with high need. Fentanyl was detected in approximately 70 percent of all deaths in rural Michigan counties in 2020.
Nonfatal Overdoses and Continued Risk Factors
Overdose deaths have declined by a lot, but nonfatal overdoses remain high across adult opioid use Michigan populations. Sustained funding and community participation are critical to turn the tide on the opioid crisis, along with a continued focus on reducing stigma. Data from the Michigan Overdose Data to Action Dashboard tracks both fatal and nonfatal overdoses through various visualizations.
Michigan Opioid Laws and Prescription Monitoring
Michigan Automated Prescription System (MAPS) tracks schedules 2-5 controlled substance prescriptions dispensed in or into Michigan. Public Act 248 of 2017 requires prescribers to register with MAPS and review a MAPS report before prescribing a Schedule 2-5 controlled substance exceeding a three-day supply.
PA 246 of 2017 requires prescribers to provide opioid education using the Start Talking Form at the time they prescribe an opioid drug. Michigan passed a naloxone Standing Order law in 2016 that pre-authorizes pharmacists to dispense naloxone to any Michigan resident. Almost 60 percent of pharmacies in Michigan were registered under the naloxone Standing Order by 2019. Michigan’s PDMP use mandate implementation was associated with a 5.0 percent decrease in mean total MMEs in discharge opioid prescriptions.
Learn More
Michigan’s three-year decline in opioid overdose deaths demonstrates meaningful progress through coordinated interventions. Settlement funding and expanded treatment access have contributed to this reduction, along with wide-reaching naloxone distribution. The challenge persists though. Nonfatal overdoses remain elevated, and racial disparities continue. Rural communities face treatment access barriers. Sustained investment in evidence-based programs will determine whether you witness further improvements in adult opioid use outcomes in Michigan. This requires ongoing community participation and stigma reduction efforts.